Opioid prescribing trends and pain scores among adult patients with cancer in a large health system
In the context of widespread policy changes, this study showed a modest decline in new and additional opioid prescribing for patients with cancer. In metastatic cancer, prescribing remained stable for patients reporting pain and declined steeply for those reporting no pain.
Authors
- David J. Graham (ORCID: https://orcid.org/0000-0002-7469-4047)
- Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
- Laura Van Metre Baum (ORCID: https://orcid.org/0000-0002-4853-6213)
- Henry Soo-Min Park (ORCID: https://orcid.org/0000-0002-9366-8514)
- Molly M. Jeffery (ORCID: https://orcid.org/0000-0003-3854-6810)
- Mark Liberatore
- Donna R. Rivera (ORCID: https://orcid.org/0000-0002-4565-4556)
- Vikram Jairam (ORCID: https://orcid.org/0000-0001-6602-7204)
- Michael Leapman (ORCID: https://orcid.org/0000-0002-0727-7614)
- Cary P. Gross (ORCID: https://orcid.org/0000-0002-4974-935X)
- Madhav KC (ORCID: https://orcid.org/0000-0002-4659-4348)
- Michaela A. Dinan (ORCID: https://orcid.org/0000-0003-4849-4743)
- Hana Lee (ORCID: https://orcid.org/0000-0002-4059-4195)
- Catherine C. Lerro
- Pamela R. Soulos
Institutions
- Sutter Health (US)
- United States Food and Drug Administration (US)
- Mayo Clinic (US)
- Center for Drug Evaluation and Research (US)
- Yale Cancer Center (US)
- Yale University (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1002/cncr.70027
- Citations
- 1
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 2.19
Funders
- U.S. Department of Health and Human Services